XML 55 R13.htm IDEA: XBRL DOCUMENT
v3.24.3

Other Financial Statement Details | 9 Months Ended
--- | ---
Sep. 28, 2024
Other Financial Statement Details [Abstract] |
Other Financial Statement Details |
Note 5 : | Other Financial Statement Details
Accounts Receivable We sell certain of our accounts receivable on a non-recourse basis to third-party financial institutions. We record these transactions as sales of receivables and present cash proceeds as cash provided by operating activities in the Consolidated Condensed Statements of Cash Flows. Accounts receivable sold under non-recourse factoring arrangements were $1.5 billion during the first nine months of 2024 and 2023. After the sale of our accounts receivable, we expect to collect payment from the customers and remit it to the third-party financial institution. Inventories
(In Millions) |  | Sep 28, 2024 |  | Dec 30, 2023
Raw materials |  | $ | 1,434 |  |  | $ | 1,166 |
Work in process |  | 6,971 |  |  | 6,203 |
Finished goods |  | 3,657 |  |  | 3,758 |
Total inventories |  | $ | 12,062 |  |  | $ | 11,127 |
Property, Plant, and Equipment We invest in and deploy manufacturing assets in response to manufacturing capacity requirements based upon short- and long-term demand forecasts and economic returns relative to capital outlays. We regularly monitor, evaluate, and adjust our manufacturing capacity footprint in response to a number of volatile factors that impact our business, including demand for our products and services and the state of the semiconductor industry as a whole. In connection with the preparation of our Consolidated Condensed Financial Statements for the third quarter of 2024, we evaluated our current process technology node capacities relative to projected market demand for our products and services, concluding that our manufacturing asset portfolio, primarily for our Intel 7 process node, exceeded manufacturing capacity requirements. Upon performing a re-use assessment, we impaired and accelerated depreciation for certain manufacturing assets. In total, we recorded non-cash impairments and accelerated depreciation charges of $2.1 billion and $945 million, respectively, in the third quarter of 2024, substantially all of which were recognized in cost of sales within our Intel Foundry operating segment. We also incurred certain other non-cash asset impairment charges of $442 million as a direct result of the 2024 Restructuring Plan (see "Note 6: Restructuring and Other Charges" within Notes to Consolidated Condensed Financial Statements). These charges were included as a component of "corporate unallocated expenses" within the restructuring and other category presented in "Note 2: Operating Segments" within Notes to Consolidated Condensed Financial Statements. Coinciding with the analysis described above and due to the reduction in our market capitalization relative to the net book value of our assets, we tested our asset groupings for impairment. As a result of that testing, which evaluated whether the carrying value of our asset group is recoverable through the related undiscounted cash flows, we concluded that the remaining carrying value of property, plant, and equipment is recoverable as of September 28, 2024. Other Accrued Liabilities Other accrued liabilities include deferred compensation of $3.2 billion as of September 28, 2024 ($2.9 billion as of December 30, 2023). Interest and Other, Net
|  | Three Months Ended |  | Nine Months Ended
(In Millions) |  | Sep 28, 2024 |  | Sep 30, 2023 |  | Sep 28, 2024 |  | Sep 30, 2023
Interest income |  | $ | 340 |  |  | $ | 332 |  |  | $ | 983 |  |  | $ | 979 |
Interest expense |  | (248) |  |  | (204) |  |  | (800) |  |  | (611) |
Other, net |  | 38 |  |  | 19 |  |  | 172 |  |  | 144 |
Total interest and other, net |  | $ | 130 |  |  | $ | 147 |  |  | $ | 355 |  |  | $ | 512 |
Interest expense is net of $392 million of interest capitalized in the third quarter of 2024 and $1.1 billion in the first nine months of 2024 ($395 million in the third quarter of 2023 and $1.1 billion in the first nine months of 2023).

X
- Definition Other Financial Statement Details [Abstract] + References No definition available. + Details
Name: | intc_OtherFinancialStatementDetailsAbstract
Namespace Prefix: | intc_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Other Financial Statement Details [Text Block] + References No definition available. + Details
Name: | intc_OtherFinancialStatementDetailsTextBlock
Namespace Prefix: | intc_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration